Association of erythropoietin gene polymorphisms with retinopathy in a Chinese cohort with type 2 diabetes mellitus

Clinical and Experimental Ophthalmology

Volumn 43, Issue 6, 2015, Pages 544-549

  Song, Qi ^a   Zhang, Yue ^a   Wu, Yongzhong ^b   Zhou, Fang ^a   Qu, Yi ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Chinese; Erythropoietin; Retinopathy; Single nucleotide polymorphism; Type 2 diabetes mellitus

Indexed keywords

ERYTHROPOIETIN; EPO PROTEIN, HUMAN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINA; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; EPO GENE; FEMALE; GENE; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; COMPLICATION; EPIDEMIOLOGY; GENE FREQUENCY; GENETICS; GENOTYPING TECHNIQUE; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; POLYMERASE CHAIN REACTION;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHINA; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ERYTHROPOIETIN; FEMALE; GENE FREQUENCY; GENOTYPE; GENOTYPING TECHNIQUES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84938199298     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/ceo.12505     Document Type: Article

References (27)

1. Resnikoff S, Pascolini D, Etya'ale D etal. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844-851.
2. Fong DS, Aiello L, Gardner TW etal. Retinopathy in diabetes. Diabetes Care 2004; 27 (Suppl. 1): S84-87.
3. Ferrara N. Vascular endothelial growth factor. The trigger for neovascularization in the eye. Lab Invest 1995; 72: 615-618.
4. Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuck KH. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res 2002; 64: 326-333.
5. Cohen T, Nahari D, Cerem LW, Neufeld G, Levi BZ. Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 1996; 271: 736-741.
6. Hammes HP, Weiss A, Hess S etal. Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. Lab Invest 1996; 75: 325-338.
7. Watanabe D, Suzuma K, Matsui S etal. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 2005; 353: 782-792.
8. Hernandez C, Fonollosa A, Garcia-Ramirez M etal. Erythropoietin is expressed in the human retina and it is highly elevated in the vitreous fluid of patients with diabetic macular edema. Diabetes Care 2006; 29: 2028-2033.
9. Katsura Y, Okano T, Matsuno K etal. Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy. Diabetes Care 2005; 28: 2252-2254.
10. Grimm C, Wenzel A, Groszer M etal. HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 2002; 8: 718-724.
11. Fisher JW. Erythropoietin: physiology and pharmacology update. Exp Biol Med (Maywood) 2003; 228: 1-14.
12. McVicar CM, Hamilton R, Colhoun LM etal. Intervention with an erythropoietin-derived peptide protects against neuroglial and vascular degeneration during diabetic retinopathy. Diabetes 2011; 60: 2995-3005.
13. Wang Y, Ng MC, Lee SC etal. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes. Diabetes Care 2003; 26: 2410-2415.
14. Zhang J, Wu Y, Jin Y etal. Intravitreal injection of erythropoietin protects both retinal vascular and neuronal cells in early diabetes. Invest Ophthalmol Vis Sci 2008; 49: 732-742.
15. Li W, Sinclair SH, Xu GT. Effects of intravitreal erythropoietin therapy for patients with chronic and progressive diabetic macular edema. Ophthalmic Surg Lasers Imaging 2010; 41: 18-25.
16. Abhary S, Burdon KP, Casson RJ, Goggin M, Petrovsky NP, Craig JE. Association between erythropoietin gene polymorphisms and diabetic retinopathy. Arch Ophthalmol 2010; 128: 102-106.
17. Tong Z, Yang Z, Patel S etal. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications. Proc Natl Acad Sci U S A 2008; 105: 6998-7003.
18. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003; 26 (Suppl. 1): S5-20.
19. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs - an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 1991; 98: 786-806.
20. Balasubbu S, Sundaresan P, Rajendran A etal. Association analysis of nine candidate gene polymorphisms in Indian patients with type 2 diabetic retinopathy. BMC Med Genet 2010; 11: 158.
21. Chen J, Connor KM, Aderman CM, Smith LE. Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 2008; 118: 526-533.
22. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
23. Hietala K, Forsblom C, Summanen P, Groop PH. Heritability of proliferative diabetic retinopathy. Diabetes 2008; 57: 2176-2180.
24. Looker HC, Nelson RG, Chew E etal. Genome-wide linkage analyses to identify Loci for diabetic retinopathy. Diabetes 2007; 56: 1160-1166.
25. Placha G, Canani LH, Warram JH, Krolewski AS. Evidence for different susceptibility genes for proteinuria and ESRD in type 2 diabetes. Adv Chronic Kidney Dis 2005; 12: 155-169.
26. Iyengar SK, Abboud HE, Goddard KA etal. Genome-wide scans for diabetic nephropathy and albuminuria in multiethnic populations: the family investigation of nephropathy and diabetes (FIND). Diabetes 2007; 56: 1577-1585.
27. Broer L, Lill CM, Schuur M etal. Distinguishing true from false positives in genomic studies: P values. Eur J Epidemiol 2013; 28: 131-138.